Hyperfine Inc., the health technology company behind the first FDA-cleared portable magnetic resonance (MR) brain imaging system — the Swoop system — announced that the company participated in the American Society of Neuroradiology (ASNR) 2024 Annual Meeting held in Las Vegas. This event featured several sessions showcasing the unique capabilities of the Swoop Portable MR Imaging® system. There was significant additional focus on the importance of MRI in the care of Alzheimer’s patients—an area of great opportunity for portable MR imaging.
Highlights from the 2024 ASNR Annual Meeting include:
- Ultra-low-field, portable MR brain imaging was featured as a high-potential technology that could have significant diagnostic impact across many disease states.
- Pioneering users of the Swoop® system showcased their clinical experience and workflow implementation in their centers.
- The substantial need for Alzheimer’s treatment-related MRI and the gap in the ability to support that need with current diagnostic capacity was reinforced multiple times on the podium.
- Several educational sessions focused on the use of MRI for monitoring amyloid-related imaging abnormalities (ARIA) and the importance of diagnosing ARIA to ensure the safe deployment and continuation of Alzheimer’s treatments.
“In my over 30 years of experience as a senior member of the ASNR, I have never seen such excitement and trepidation in the neuroradiology community in the care of specific disease states. The enthusiasm shown by my fellow neuroradiologists for the diagnosis and management of Alzheimer’s disease was overwhelming, as was the concern for how this can be handled with the current imaging infrastructure. By bringing ultra-low-field, portable MR brain imaging into the neuroradiology armamentarium, attendees immediately saw the significant potential benefit of this technology in the care of these patients,” said Edmond Knopp, MD, Vice President of Medical Affairs at Hyperfine, Inc.
For more information about the Swoop Portable MR Imaging system, visit hyperfine.io.
